AM

Ajay Mishra

Director Additional Director DIN 09494382
DIN 09494382 First appointment Feb 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Ajay Mishra

Data last updated:

Ajay Mishra was an Additional Director at Zee Laboratories Limited (2022) and Director at Hnc Biotech Private Limited (from 2022). The companies operate in Pharma.

DIN 09494382
Primary Designation Additional Director
Industry Pharma
First Appointment 05 Feb 2022
Oldest Company Age 4 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zee Laboratories Limited U74899DL1994PLC061704
Additional Director05 Feb 20221994₹464 Cr (FY 2024)Active
Hnc Biotech Private Limited U51397DL2022PTC403230
Director17 Aug 20222022Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hnc Biotech Private Limited
Zee Laboratories Limited
Premium access

Shareholding and investment profile for Ajay Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajay Mishra

Ajay Mishra was first appointed on 05 Feb 2022 as Additional Director at Zee Laboratories Limited.

Ajay Mishra held 2 earlier board appointments: Zee Laboratories Limited (Additional Director, 05 Feb 2022 to 28 Apr 2022); Hnc Biotech Private Limited (Director, from 17 Aug 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available